Using a Fibrinolysis Delivery Catheter in Pulmonary Embolism Treatment for Measurement of Pulmonary Artery Hemodynamics.
Abdelrahman ElhakimMartin KnauthMohamed ElhakimUlrich BöhmerJohannes PatzeltPeter RadkePublished in: Advances in respiratory medicine (2022)
Pulmonary artery hemodynamics were assessed using a delivery catheter for fibrinolysis, which is reproducible for identifying PE at risk of adverse outcomes. The results matched the right heart catheter results in EKOS and Heparin arm of Ultima trial, thereby confirming the validity of this potential diagnostic tool to assess therapy effectiveness and thereby reduce additional procedure-related complications, hospital residency, and economics. These results stress the importance of having an interdisciplinary team involved in the management of PE to evaluate the quality of life of these patients and this protocol shortens ICU admission to 6 h.
Keyphrases
- pulmonary artery
- pulmonary embolism
- coronary artery
- pulmonary hypertension
- pulmonary arterial hypertension
- randomized controlled trial
- end stage renal disease
- ejection fraction
- inferior vena cava
- emergency department
- newly diagnosed
- chronic kidney disease
- systematic review
- healthcare
- heart failure
- study protocol
- clinical trial
- atrial fibrillation
- risk factors
- mesenchymal stem cells
- growth factor
- mechanical ventilation
- phase ii
- acute care
- phase iii
- replacement therapy
- adverse drug
- climate change
- electronic health record